Treatment of Lymphedema of the Arms and Legs with 5,6-Benzo-[alpha]-pyrone
- 14 October 1993
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (16), 1158-1163
- https://doi.org/10.1056/nejm199310143291604
Abstract
Benzopyrones can reduce the volume of high-protein edema fluid by stimulating proteolysis. These compounds provide a method for removing excess protein and its consequent edema and reduce its clinical sequelae, such as chronic inflammation and secondary infections.Keywords
This publication has 5 references indexed in Scilit:
- Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-α-pyrone (coumarin), and the effects of diethylcarbamazine (DEC)Pathogens and Global Health, 1993
- MODERN TREATMENT OF LYMPHOEDEMA I. COMPLEX PHYSICAL THERAPY: THE FIRST 200 AUSTRALIAN LIMBSAustralasian Journal of Dermatology, 1992
- The Lymphedema Chaos: A LancetAnnals of Plastic Surgery, 1989
- A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legsBritish Journal of Plastic Surgery, 1988
- Excess plasma proteins as a cause of chronic inflammation and lymphoedema: Quantitative electron microscopyThe Journal of Pathology, 1981